Infectious Diseases News and Research

RSS

Multi-country study examines clinical and community antibiotic use during the pandemic

Globally, during the first two years of the COVID-19 pandemic, antibiotics were prescribed to 75 percent of COVID-19 patients despite bacterial coinfection rates averaging less than 10 percent.

6 Feb 2023

Cancer-causing viruses use a human protein to evade the innate immune response

The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers.

6 Feb 2023

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

The Access to Advanced Health Institute announced today that it has been awarded a project agreement worth up to $9.9 million through the Medical CBRN Defense Consortium Other Transaction Authority to develop a prototype intranasal bivalent influenza RNA vaccine candidate based on AAHI's self-amplifying RNA (saRNA) platform that targets both pandemic A(H5N1) and A(H7N9) influenza virus pathogens.

6 Feb 2023

A technicality could keep RSV shots from kids in need

After more than five decades of trying, the drug industry is on the verge of providing effective immunizations against the respiratory syncytial virus, which has put an estimated 90,000 U.S. infants and small children in the hospital since the start of October.

6 Feb 2023

Demographic factors influencing COVID vaccine acceptance rates among healthcare workers worldwide

Researchers determine the factors that influence the perceptions on and acceptance of COVID-19 vaccines among healthcare workers.

5 Feb 2023

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

3 Feb 2023

The human body develops strategies to prevent the immune response from overshooting its mark

The signaling molecules of the immune system should trigger a response only where necessary. To prevent a life-threatening spread to the rest of the body, connective tissue can absorb these molecules like a sponge.

3 Feb 2023

Researchers explore mass gatherings and COVID-19 transmission

A recent study examines how mass gatherings in Hong Kong were associated with the local transmission of SARS-CoV-2.

3 Feb 2023

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies

Not all SARS-CoV-2 infections are created equal. We have learned this through multiple virus waves are taking their toll on the world's population.

3 Feb 2023

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future.

From Oncodesign Services 3 Feb 2023

Experts outline NIH's COVID-19 research response

Leaders from the National Institutes of Health and partner organizations outline NIH's COVID-19 research response in a policy forum in the journal Science.

2 Feb 2023

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

Researchers examines the effectiveness of the Pfizer-BioNTech COVID-19 vaccine among long-term care facility staff members.

2 Feb 2023

BCG vaccine does not protect elderly with co-morbidities against COVID-19

The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection.

2 Feb 2023

Immunocompromised patients more likely to die if hospitalized with COVID-19, study confirms

People with weakened immune systems remain more likely to die if hospitalized with COVID-19 than patients with normal immune systems, a new UK study has confirmed.

1 Feb 2023

Researchers utilize discarded facial tissues to diagnose respiratory viral infections in children

Researchers developed an innovative method to diagnose respiratory viral infections (RVIs) in children using discarded facial tissues.

1 Feb 2023

Risk factors for Omicron reinfections among previously infected frontline workers in the United States

Researchers examined a prospective cohort of frontline workers in the United States (US) previously infected with SARS-CoV-2. They attempted to identify risk factors that made this highly vulnerable population prone to reinfection by SARS-CoV-2 new variant of concern (VOC), Omicron, known for its high immune evading potential.

1 Feb 2023

Infectious Diseases News and Research

Multi-country study examines clinical and community antibiotic use during the pandemic

Cancer-causing viruses use a human protein to evade the innate immune response

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

A technicality could keep RSV shots from kids in need

Demographic factors influencing COVID vaccine acceptance rates among healthcare workers worldwide

Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

The human body develops strategies to prevent the immune response from overshooting its mark

Researchers explore mass gatherings and COVID-19 transmission

New electrochemical sensing technology enables detection of SARS-CoV-2 antigen-specific antibodies

Oncodesign Services looks to the future

Experts outline NIH's COVID-19 research response

Pfizer COVID-19 vaccine protects against reinfection in long-term care facility staff

BCG vaccine does not protect elderly with co-morbidities against COVID-19

Immunocompromised patients more likely to die if hospitalized with COVID-19, study confirms

Researchers utilize discarded facial tissues to diagnose respiratory viral infections in children

Risk factors for Omicron reinfections among previously infected frontline workers in the United States

Analysis of rebound virus suggests two separate reservoirs of latent HIV in patients

Researchers develop new way to increase the potency of cancer vaccines

Study demonstrates intrahost MPXV variation within a single lesion

Study: COVID-19 is a significant cause of death in children and young people in the U.S.

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News